| 21/28 | US=84-A / Biol/Mol Fukuchi M, Kato H, Kuwano H. Transformig growth factor-B in developing and advanced cancers: TGF-B and progression of esophageal cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 133-40. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 22/28 | US=84-A / Biol/Mol Todorovic-Rakovic N. Transformig growth factor-B in developing and advanced cancers: TGF-B and HER2/ErbB2 and beast cancer progression. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 141-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; HER2; CANCER DE MAMA; SMAD; RAS/MAPK; SINERGISMO; PROGRESSAO |
| 23/28 | US=84-A / Biol/Mol Wolfrain LA, Letterio JJ. Transformig growth factor-B in developing and advanced cancers: perturbations of TGF-B signaling in leukocytes as drivers of leukemogenesis and epithelial tumorigenesis. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 181-202. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FATOR TRANSFORMADOR DE CRESCIMENTO - B; TGF-B; SMAD; LEUCEMOGENESE; CELULAS T; IMUNOTERAPIA TUMOR; MODELOS DE RATO; ESTROMA; LINFOCITOS EPITELIAIS INTERACCOES |
| 24/28 | US=84-A / Biol/Mol Ruscetti F, Akel S, Birchenall-Roberts M, Cao Z, Roberts AB. Transformig growth factor-B in developing and advanced cancers: smad signaling in leukemic growth and differentiation: crosstalk between smad and multiple pathways through activation of the TGF-B type I receptor. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 247-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FATOR TRANSFORMADOR DE CRESCIMENTO - B; LEUCEMIA; DIFERENCIACAO; CROSSTALK SMAD SINALIZACAO; MAPK SINALIZACAO TUBERINA |
| 25/28 | US=84-A / Biol/Mol Bommireddy R, Doetschman T. Transformig growth factor-B in developing and advanced cancers: tumor suppressor functions of TGFB1 in T cells. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 353-66. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FOXP3; SMAD; TGF-B1; TREG CELULAS; TUMORES; CALCIO; AUTOIMUNIDADE; CAMUNDONGOS KNOCKOUT; CELULAS T |
| 26/28 | US=84-A / Biol/Mol Dennler S, Mawviel A, Verrecchia F. Transformig growth factor-B in developing and advanced cancers: TGF-B and stromal influences over local tumor invasion. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 537-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 27/28 | US=84-A / Biol/Mol Hoffmann FM, Cui Q, Lim SK, Zhao BM. Development of inhibitors of transforming growth factor-B signaling for therapy: targeting smad-dependent TGF-B signaling with peptide aptamers. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 737-56. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. APTAMEROS PEPTIDEO; MOTIVO DE PROTEINA; PROTEINA ANDAIME; SMAD; TGF-B INIBIDORES |
| 28/28 | US=61 / Câncer Pinkas J, Teicher BA. The role of hormones, growth factors, and oncogenes: role of TGF-b in tumor progression and metastasis. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 469-89. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. FATOR DE CRESCIMENTO TRANSFORMANTE-B; RECEPTOR DO FATOR DE CRESCIMENTO TRANSFORMANTE-B; SMAD; OSTEOCLASTOS; FIBROSE |